MYELOFIBROSIS: PROGNOSTIC FACTORS AND TREATMENT
- 1 July 1988
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 69 (3) , 295-298
- https://doi.org/10.1111/j.1365-2141.1988.tb02365.x
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- INTERFERON IN MYELOFIBROSISThe Lancet, 1988
- Ultrasonic characterization of splenic tissue in myelofibrosis: Further evidence for reversal of fibrosis with chemotherapyEuropean Journal of Haematology, 1988
- ALPHA-INTERFERON IN PRIMARY IDIOPATHIC MYELOFIBROSISThe Lancet, 1987
- Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasiaEuropean Journal of Haematology, 1987
- 1.25 DIHYDROXY-VITAMIN D5 (1.25 (OH), vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSISBritish Journal of Haematology, 1987
- A ROLE FOR 1,25-DIHYDROXYVITAMIN D3 IN CONTROL OF BONE-MARROW COLLAGEN DEPOSITION?The Lancet, 1984
- The Syndrome of Idiopathic MyelofibrosisMedicine, 1983
- Different Composition of the Erythropoietic Tissue in Bone Marrow, Spleen and Liver in MyelofibrosisActa Haematologica, 1978
- Effect of splenectomy on teardrop-shaped erythrocytes in agnogenic myeloid metaplasiaArchives of internal medicine (1960), 1977
- The Pathogenesis of Spleen Mediated Phenomena in Chronic Myeloid Leukaemia and Agnogenic Myeloid Metaplasia: A Non Abscopal MechanismScandinavian Journal of Haematology, 1976